ArticleBiomaterials2021

Drug-eluting immune checkpoint blockade antibody-nanoparticle conjugate enhances locoregional and systemic combination cancer immunotherapy through T lymphocyte targeting.

David M Francis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.